Device Trial Radar · NCT07948967
Physiological Associations and Prognostic Discrimination of an EIT-Derived Flow Index During Noninvasive Ventilation
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Dec 1, 2026
Primary completion
Sep 30, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Ruijin HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Shanghai East Hospital; Zhoukou Central Hospital; The First Affiliated Hospital of Soochow University
- First posted
- Nov 19, 2026
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter prospective observational cohort study with a nested physiological substudy. It aims to enroll 220 adults with acute hypoxemic respiratory failure (AHRF) initiating mask noninvasive ventilation (NIV). The study will assess the measurement feasibility, physiological associations, and early prognostic discrimination of the electrical impedance tomography (EIT)-derived flow index (EFI) during NIV. The primary objective is to estimate how well pre-landmark T1 EFI discriminates the risk of endotracheal intubation or all-cause death through 48 hours. A nested physiological substudy (n=20) will evaluate the within-patient association between EFI and airway occlusion pressure across fixed pressure support (PS) levels (5, 10, and 15 cmH2O). Clinical management remains independent of study measurements.
Conditions
- Acute Hypoxemic Respiratory Failure
- Noninvasive Ventilation
Interventions
Noninvasive Ventilation (NIV)Other
Standard clinical care through oronasal or full-face mask. Settings are directed by the treating team.
Electrical Impedance Tomography (EIT) MonitoringDevice
Continuous EIT monitoring to derive the dimensionless flow index (EFI).
Brief Pressure Support Adjustment and Airway Occlusion (Substudy only)Other
Protocol-specified PS steps (5, 10, 15 cmH2O) and device-supported airway occlusions performed in the physiological substudy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Endotracheal Intubation or All-Cause Death (2h to 48h)Time frame: After 2 hours through 48 hours.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.